Bio Essence (BIOE) Gains from Investment Securities (2021 - 2026)

Bio Essence's Gains from Investment Securities history runs 5 years deep, the most recent figure standing at $800.0 for Q1 2026.

• In Q1 2026, Gains from Investment Securities changed N/A year-over-year to $800.0; the TTM figure through Mar 2026 stood at $4612.0 (changed N/A YoY), while the FY2025 annual figure was $800.0, changed 0.0% from the prior year.
• Gains from Investment Securities was $800.0 for Q1 2026 at Bio Essence, down from $3812.0 in the prior quarter.
• In the past five years, Gains from Investment Securities ranged from a high of $1.6 million in Q4 2023 to a low of -$3012.0 in Q1 2024.
• Historically, Gains from Investment Securities has averaged $317672.6 across 4 years, with a median of $800.0 in 2026.
• Biggest YoY gain for Gains from Investment Securities was 1586563.0% in 2023; the steepest drop was 1586563.0% in 2023.
• A 4-year view of Gains from Investment Securities shows it stood at $100.0 in 2022, then surged by 1586563.0% to $1.6 million in 2023, then slumped by 99.76% to $3812.0 in 2024, then tumbled by 79.01% to $800.0 in 2026.
• The last three Gains from Investment Securities figures came in at $800.0 (Q1 2026), $3812.0 (Q2 2024), and -$3012.0 (Q1 2024), per Business Quant data.